- Remixed Lidocaine Hydrochloride in 5% Dextrose Injection solution. It contains 2 grams of Lidocaine HCl (0.4%) in a 500 mL EXCEL® IV container, delivering a concentration of 4mg/mL
Uses
- Acute Ventricular Arrhythmias:
- Specifically indicated for managing life-threatening arrhythmias of ventricular origin, such as those occurring during an acute myocardial infarction
- Cardiac Procedures:
- Used to manage ventricular arrhythmias that occur during cardiac surgery or other cardiac manipulations
Features
- Concentration:
- A standardized strength of 4 mg/mL (2 grams total in 500mL)
- EXCEL® Container:
- A flexible bag made of a multi-layered film that is not made with PVC, DEHP, or natural rubber latex, which prevents plasticizer leaching into the medication
- Closed System:
- The container-solution unit does not require external air for administration, maintaining a sterile environment during the infusion
- Preservative-Free:
- Contains no antimicrobial or bacteriostatic agents
- Tamper-Evident Ports:
- The administration set port features a tamper-evident plastic protector to ensure product integrity
Benefits
- Patient Safety:
- The PVC-free and DEHP-free design is biologically inert and non-toxic, making it safer for sensitive patients and reducing the risk of drug adsorption to the bag walls
- Clinical Efficiency:
- Premixed ready-to-use bags eliminate manual admixture steps, saving nursing and pharmacy time and reducing the potential for contamination and medication calculation errors
- Accurate Dosing:
- Standardized concentrations allow for precise titration of the antiarrhythmic dose based on patient response
- Sustainability:
- Upon incineration, the EXCEL® container material decomposes into carbon dioxide and water, reducing the environmental impact and landfill disposal costs compared to PVC-based containers
Contents
- 0.4% Lidocaine Hydrochloride in 5% Dextrose for Injection in 500mL EXCEL IV Container
- 24 Bags per case
